NovoCure Ltd
| Volume: | 212,292 | Avg Vol (1m): | 527,582 |
| Market Cap $: | 5.66 Bil | Enterprise Value $: | 5.56 Bil |
| P/E (TTM): | 0.00 | P/B: | 44.33 |
| Earnings Power Value | -24.01 |
| Net Current Asset Value | 0.97 |
| Tangible Book | 1.33 |
| Projected FCF | 0 |
| Median P/S Value | 36.94 |
| Graham Number | 0 |
| Peter Lynch Value | 0 |
| DCF (FCF Based) | 0 |
| DCF (Earnings Based) | 0 |
Manual of Stocks™ Web
GuruFocus Articles
Total 4
- 1
- 1
NEW YORK, March 29, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Apple Hospitality REIT, Inc. (:APLE), Superior Energy Services, Inc. (:SPN), US Foods Holding Corp. (:USFD), NovoCure Limited (NVCR), FTS International, Inc. (:FTSI), and Envestnet, Inc (:ENV), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the
NEW YORK, Dec. 07, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Moody's Corporation (:MCO), Hershey Company (:HSY), NovoCure Limited (NVCR), Mohawk Industries, Inc. (:MHK), La-Z-Boy Incorporated (:LZB), and Lockheed Martin Corporation (:LMT), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
MCO DOWNLOAD:
SHANGHAI, China, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Zai Lab Limited ( ZLAB), a Shanghai-based innovative biopharmaceutical company, and Novocure Limited ( NVCR) today announced that they have received the Deal of the Year Award at the 9th Annual BayHelix Awards Lunch Banquet held during the annual BioCentury-BayHelix China Healthcare Summit in Shanghai, China. The annual award recognizes a groundbreaking collaboration, technology transfer, licensing, capital raising, M&A or joint venture that involves a Chinese company in the healthcare sector. In September of this year, Zai Lab
NEW YORK, June 15, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of NovoCure Limited (NVCR), Canada Goose Holdings Inc. (:GOOS), Telephone and Data Systems, Inc. (:TDS), FMC Corporation (:FMC), MobileIron, Inc. (MOBL), and Viking Therapeutics, Inc. (VKTX), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links
Headlines
Total 137
- 1
- 2
- 1
- 2
| 2019-06-17 $58.04 (5.37%) | |
11:31pm | U.S. Steel, Insperity, NovoCure: 'Mad Money' Lightning Round - www.thestreet.com |
| 2019-06-12 $55.78 (2.67%) | |
4:39pm | |
| 2019-06-06 $54.74 (-0.22%) | |
1:56pm | |
7:50am | Why NovoCure Stock Jumped 20.5% in May -- - www.fool.com |
| 2019-05-24 $52.91 (7.3%) | |
1:14pm | |
| 2019-05-13 $48.4 (-1.83%) | |
3:00am | Insulet and Novocure Are Going Gangbusters -- - www.fool.com |
| 2019-05-10 $49.3 (0.16%) | |
12:02pm | |
| 2019-05-07 $47.62 (-2.66%) | |
10:38am | 5 Key Takeaways From NovoCure's Big First-Quarter -- - www.fool.com |
| 2019-05-03 $48.89 (9.62%) | |
12:48am | NovoCure Limited (NVCR) Q1 2019 Earnings Call Transcript -- - www.fool.com |
| 2019-05-02 $44.6 (3.05%) | |
12:53pm | |
12:02pm | NovoCure Limited (NVCR) Q1 2019 Earnings Call Transcript -- - www.fool.com |
8:11am | |
6:30am | NovoCure (NVCR) Reports Q1 Loss, Misses Revenue Estimates - www.zacks.com |
| 2019-05-01 $43.28 (-1.79%) | |
5:00pm | 3 Top Chinese Stocks to Watch in May -- - www.fool.com |
| 2019-04-29 $44.97 (0.18%) | |
8:34pm | Twilio, Aurora Cannabis, Levi's: 'Mad Money' Lightning Round - www.thestreet.com |
| 2019-04-25 $45.05 (-0.13%) | |
9:33am | |
| 2019-04-06 | |
3:45pm | Why Novocure Stock Fell More Than 10% in March -- - www.fool.com |
| 2019-03-08 $48.07 (0.67%) | |
7:45am | Options Traders Expect Huge Moves in NovoCure (NVCR) Stock - www.zacks.com |
| 2019-02-28 $53.71 (-0.5%) | |
3:21pm | |
1:32pm | |
10:37am | |
| 2019-01-10 $42 (3.78%) | |
3:32pm | |
| 2018-12-19 $32.24 (-1.86%) | |
2:06pm | |
| 2018-11-12 $30.55 (-7.87%) | |
6:45pm | $NVCR Novocure Interesting Cure Portfolio - seekingalpha.com |
| 2018-10-25 $33.64 (-18.98%) | |
12:40pm | |
11:20am | $NVCR Novocure 2018 Q3 Results Earnings Call Slides - seekingalpha.com |
8:05am | NovoCure (NVCR) Reports Q3 Loss, Misses Revenue Estimates - www.zacks.com |
| 2018-10-18 $45.04 (-0.84%) | |
9:33am | NovoCure (NVCR) Q3 Earnings Preview: What to Look Out For - www.zacks.com |
| 2018-10-17 $45.42 (-1.69%) | |
7:36am | |
| 2018-10-02 $51.82 (-1.52%) | |
7:18am | |
| 2018-10-01 $52.62 (0.42%) | |
8:06pm | Lululemon Athletica, Starbucks, Snap: 'Mad Money' Lightning Round - www.thestreet.com |
| 2018-09-27 $51.85 (1.67%) | |
5:31pm | $NVCR Novocure 3 Takeaways Detailed Mesothelioma Data - seekingalpha.com |
| 2018-09-26 $51 (0.59%) | |
1:52pm | |
| 2018-09-18 $49.05 (5.83%) | |
7:30am | |
| 2018-09-17 $46.35 (-4.04%) | |
4:29am | |
| 2018-09-12 $47.1 (4.43%) | |
11:55am | $NVCR Novocure Projecting Glioblastoma Mesothelioma Revenues - seekingalpha.com |
7:38am | |
| 2018-09-10 $45.25 (-4.13%) | |
1:10pm | |
| 2018-09-07 $47.2 (3.96%) | |
1:26pm | |
9:03am | $NVCR Cancer Highlight Novocure Vaults Thoracic Oncology - seekingalpha.com |
| 2018-09-06 $45.4 (5.34%) | |
4:09pm | |
| 2018-09-04 $44.95 (-0.22%) | |
10:00am | |
| 2018-08-16 $36.5 (-0.14%) | |
2:43pm | |
| 2018-08-01 $34.85 (2.5%) | |
2:49am | $NVCR Buy Dip Novocure - seekingalpha.com |
| 2018-07-26 $36.83 (-1.66%) | |
1:57pm | |
10:42am | $NVCR Novocure 2018 Q2 Results Earnings Call Slides - seekingalpha.com |
| 2018-07-17 $35.6 (0.14%) | |
7:54am | NovoCure (NVCR) Catches Eye: Stock Jumps 7.4% - www.zacks.com |
| 2018-06-21 $30.8 (-0.96%) | |
5:59am | |
| 2018-06-20 $31.1 (-2.81%) | |
8:35pm | Under Armour, Cognex, Novocure: 'Mad Money' Lightning Round - www.thestreet.com |
| 2018-06-15 $30.9 (-2.37%) | |
11:01am | |
2:51am | $NVCR Novocure Former Roty Contender Far Finished - seekingalpha.com |
| 2018-06-11 $30.25 (-1.63%) | |
1:51am | $APTO $CHRS $FENC $MYL $NVCR $VKTX $GBT $MDGL Clovers Weekly Leaflet - seekingalpha.com |
| 2018-06-07 $31.35 (-0.95%) | |
8:00am | |
| 2018-06-04 $29.55 (-7.51%) | |
1:02am | |
| 2018-05-26 | |
9:00am | |
| 2018-05-23 $29.8 (0.34%) | |
2:17pm | $NVCR Novocure Nvcr Presents 2018 Ubs Global Healthcare Conference Slideshow - seekingalpha.com |
| 2018-05-17 $28.4 (-2.07%) | |
10:52am | $CWBR $NVCR $SYBX 3 Young Biotechs Positioned Upend Medicine - seekingalpha.com |
| 2018-05-16 $29 (-0.34%) | |
3:55am | |
| 2018-05-14 $30 (%) | |
8:19am | |
| 2018-05-12 | |
12:23am | |
| 2018-05-10 $29.55 (1.9%) | |
1:42pm | |
| 2018-05-08 $28.25 (0.53%) | |
3:03pm | |
| 2018-05-07 $28.1 (0.36%) | |
3:40pm | |
| 2018-05-06 | |
8:58am | $BMY $FMI $GERN $NVCR $PGNX Bs Report Week 12 Living Yawnsville Little Gains - seekingalpha.com |
| 2018-05-03 $28 (0.9%) | |
5:28am | |
| 2018-05-01 $27.6 (1.1%) | |
2:41am | |
| 2018-04-30 $27.3 (1.68%) | |
11:59am | $NVCR Novocure 2018 Strong Start Optune - seekingalpha.com |
| 2018-04-29 | |
8:44pm | $NVCR Novocure Hints Additional Stellar Data Validation - seekingalpha.com |
2:04pm | $BMY $FMI $GERN $NVCR $PGNX Bs Report Week 11 Rising Tides Sinking Ships - seekingalpha.com |
| 2018-04-26 $26.5 (9.73%) | |
4:53pm | This Explains Why NovoCure Is Surging Today - www.fool.com |
7:15am | $NVCR Novocure 2018 Q1 Results Earnings Call Slides - seekingalpha.com |
| 2018-04-25 $24.15 (-1.23%) | |
10:10am | NovoCure (NVCR) Shares March Higher, Can It Continue - www.zacks.com |
| 2018-04-18 $23.8 (2.37%) | |
7:31am | NovoCure Limited (NVCR) Looks Good: Stock Adds 7.9% in Session - www.zacks.com |
| 2018-04-13 $21.55 (-1.6%) | |
6:31pm | 3 Top Healthcare Stocks to Buy in April - www.fool.com |
| 2018-03-26 $21.75 (-0.91%) | |
3:31pm | |
| 2018-03-24 | |
5:20pm | |
| 2018-03-20 $22.45 (4.42%) | |
7:40am | |
| 2018-03-17 | |
2:48pm | |
| 2018-03-12 $22.65 (1.12%) | |
5:41am | |
| 2018-03-11 | |
2:12pm | $ADXS $BMY $FMI $GERN $NVCR $PGNX Bs Plan Week 4 Whoa - seekingalpha.com |
| 2018-03-06 $21.85 (0.46%) | |
6:40am | |
| 2018-03-05 $21.75 (0.69%) | |
2:47am | $ADXS $BMY $FMI $GERN $NVCR $PGNX Bs Plan Week 3 Report First Failure - seekingalpha.com |
| 2018-02-27 $21.15 (2.17%) | |
7:39am | |
1:12am | $NVCR Novocure Updates Thesis Stellar Data Looms - seekingalpha.com |
| 2018-02-26 $20.7 (7.25%) | |
11:14pm | |
| 2018-02-25 | |
5:31am | |
| 2018-02-22 $20.6 (-4.41%) | |
9:06am | $NVCR Novocure 2017 Q4 Results Earnings Call Slides - seekingalpha.com |
| 2018-02-20 $21.05 (-2.09%) | |
6:59am | $ADXS $BMY $FMI $GERN $NVCR $PGNX Bs Plan Week 1 Report - seekingalpha.com |
| 2018-02-19 $21.5 (%) | |
5:20am | |
| 2018-02-12 $20.5 (-2.15%) | |
12:21am | |
| 2018-02-09 $20.95 (1.45%) | |
7:54am | |
| 2018-01-19 $21.1 (1.93%) | |
2:31pm | |
| 2018-01-12 $21.7 (-2.03%) | |
11:08am | $NVCR Novocure Recent Developments Upcoming Prospects Mesothelioma - seekingalpha.com |
| 2018-01-11 $22.15 (3.02%) | |
12:39pm | |
| 2018-01-09 $21 (2.44%) | |
10:53am | Here's Why NovoCure Popped 157% in 2017 - www.fool.com |
| 2018-01-08 $20.5 (-1.44%) | |
12:55pm | |
| 2017-12-21 $20.2 (-0.49%) | |
3:41pm | |
6:00am | 3 Stocks That Could Put Amazon's Returns to Shame - www.fool.com |
| 2017-12-19 $20.25 (%) | |
10:03am | |
8:00am | $ACHN $AZN $NVCR 3 Things Biotech Learn Today December 19 2017 - seekingalpha.com |
- 1
- 2